AndrewLPecoraMD

PubMed

• 3 citations
  Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumors.
  Maher Albitar, Hong Zhang, Ahmad Charifa, Andrew Ip, Wanlong Ma, James McCloskey, Michele Donato, David Siegel, Stanley Waintraub, Martin Gutierrez, Andrew Pecora, And...> ;Heliyon. 2023 May 1
• 2 citations
  The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real-world, multicenter, retrospective study.
  Shaked Lev-Ari, Michael Serzan, Tianmin Wu, Andrew Ip, Lauren Pascual, Brittany Sinclaire, Shari Adams, Michael Marafelias, Lakshmi Ayyagari, Sarvarinder K Gill, Barba...> ;Cancer. 2023 Jun 15
• 103 citations
  Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134.
  Atkins, M., Lee, S., Chmielowski, B., Tarhini, A., Cohen, G., Truong, T., Moon, H., Davar, D., O'Rourke, M., Stephenson, J., Curti, B., Urba, W., Brell, J., Funchain, ...> ;Journal of Clinical Oncology. 2023 Jan 10
• 1 citations
  Homologous Recombination Abnormalities Associated WithMutations as Predicted by Machine Learning of Targeted Next-Generation Sequencing Data.
  Maher Albitar, Hong Zhang, Andrew Pecora, Stanley Waintraub, Deena Graham, Mira Hellmann, Donna McNamara, Ahmad Charifa, Ivan De Dios, Wanlong Ma, Andre Goy> ;Breast Cancer. 2023 Jan 1
• 7 citations
  Differential Diagnosis of Hematologic and Solid Tumors Using Targeted Transcriptome and Artificial Intelligence.
  Hong Zhang, Muhammad A Qureshi, Mohsin Wahid, Ahmad Charifa, Aamir Ehsan, Andrew Ip, Ivan De Dios, Wanlong Ma, Ipsa Sharma, James McCloskey, Michele Donato, David Sieg...> ;The American Journal of Pathology. 2023 Jan 1
• 2 citations
  Reliability of Cell-Free DNA and Targeted NGS in Predicting Chromosomal Abnormalities of Patients With Myeloid Neoplasms.
  Andrew Ip, Alexandra Della Pia, Gee Youn Geeny Kim, Jason Lofters, James Behrmann, Dylon Patel, Simone Kats, Jeffrey Justin Estella, Ivan De Dios, Wanlong Ma, Andrew L...> ;Frontiers in Oncology. 2022 Jan 1
• 6 citations
  Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence.
  Craig L. Slingluff, Karl D. Lewis, Robert H.I. Andtbacka, John R. Hyngstrom, Mohammed M. Milhem, Svetomir N. Markovic, Tawnya L. Bowles, Omid Hamid, Leonel Hernandez-A...> ;Journal for Immunotherapy of Cancer. 2021 Oct 1
• 4 citations
  Pembrolizumab, lenalidomide and dexamethasone post autologous transplant in patients with high-risk multiple myeloma.
  Noa Biran, Elli Gourna Paleoudis, Rena Feinman, David H. Vesole, Joshua Zenreich, Shuqi Wang, Jaeil Ahn, Meena Bansal, Scott D. Rowley, Michele Donato, Andrew L. Pecor...> ;American Journal of Hematology. 2021 Nov 1
• 10 citations
  Safety and Efficacy of Consolidation Therapy with Ipilimumab Plus Nivolumab after Autologous Stem Cell Transplantation.
  Alan P Skarbnik, Michele L. Donato, Rena Feinman, Scott D. Rowley, David H. Vesole, Andre Goy, Pashna N. Munshi, Tatyana Feldman, Lori A. Leslie, Noa Biran, Themba Nyi...> ;Transplantation and Cellular Therapy. 2021 May 1
• 20 citations
  Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma.
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;JCI Insight. 2021 Mar 22
• 34 citations
  Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: a multi-center observational study.
  Andrew Ip, Jaeil Ahn, Yizhao Zhou, Andre Goy, Eric Hansen, Andrew L. Pecora, Brittany A Sinclaire, Urszula Bednarz, Michael Marafelias, Ihor S. Sawczuk, Joseph P. Unde...> ;BMC Infectious Diseases. 2021 Jan 14
• 7 citations
  Development and validation of a prognostic 40-day mortality risk model among hospitalized patients with COVID-19.
  Donald A. Berry, Andrew Ip, Brett E. Lewis, Scott M. Berry, Nicholas S. Berry, Mary Mrkulic, Virginia Gadalla, Burcu Sat, Kristen Wright, Michelle Serna, Rashmi Unawan...> ;Plos One. 2021 Jul 30
• 8 citations
  Prevalence and Survival Impact of Self-Reported Symptom and Psychological Distress Among Patients With Multiple Myeloma.
  Joshua Richter, Larysa Sanchez, Noa Biran, Ching-Kun Wang, Kathryn Tanenbaum, Victoria DeVincenzo, Brooke Grunman, David H. Vesole, David S. Siegel, Andrew L. Pecora, ...> ;Clinical Lymphoma, Myeloma & Leukemia. 2017 Dec 7
• 199 citations
  Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study.
  Noa Biran, Andrew Ip, Jaeil Ahn, Ronaldo C. Go, Shuqi Wang, Shivam Mathura, Brittany A Sinclaire, Urszula Bednarz, Michael Marafelias, Eric Hansen, David S. Siegel, An...> ;The Lancet. Rheumatology. 2020 Oct 1
• 104 citations
  Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational study.
  Andrew Ip, Donald A. Berry, Eric Hansen, Andre Goy, Andrew L. Pecora, Brittany A Sinclaire, Urszula Bednarz, Michael Marafelias, Scott M. Berry, Nicholas S. Berry, Shi...> ;Plos One. 2020 Aug 13
• 8 citations
  Differential impact of cognitive computing augmented by real world evidence on novice and expert oncologists.
  Donna M. McNamara, Stuart L. Goldberg, Lisa M. Latts, Deena Graham, Stanley E. Waintraub, Andrew D. Norden, Cody Landstrom, Andrew L. Pecora, John Hervey, Eric V Schul...> ;Cancer Medicine. 2019 Sep 11
• 2 citations
  A phase I/II study of escalating doses of thalidomide in conjunction with bortezomib and high-dose melphalan as a conditioning regimen for autologous stem cell transpl...
  Noa Biran, Scott D. Rowley, David H. Vesole, Shijia Zhang, Michele L. Donato, Alan P Skarbnik, Joshua Richter, Andrew Pecora, David S. Siegel> ;Bone Marrow Transplantation. 2019 May 17
• 11 citations
  A Patient‐Reported Outcome Instrument to Assess Symptom Burden and Predict Survival in Patients with Advanced Cancer: Flipping the Paradigm to Improve Timing of Pallia...
  Stuart L. Goldberg, Dhakshila Paramanathan, Raya Khoury, Sharmi Patel, Dayo Jagun, Srikesh Arunajadai, Victoria DeVincenzo, Ruth Pe Benito, Brooke Gruman, Sukhi Kaur, ...> ;The Oncologist. 2019 Jan 1
• 5 citations
  Development of a Precise, Clinically Relevant, Digital Classification Schema for Cancer.
  Andrew L. Pecora, Andrew D. Norden, John Hervey, Eric V Schultz, Thomas L Gallucci, Elizabeth Rushforth, Stuart L. Goldberg> ;JCO Clinical Cancer Informatics. 2018 Oct 16
• 11 citations
  Prolactin Induced Protein (PIP) is a potential biomarker for early stage and malignant breast cancer
  Anju Gangadharan, Themba Nyirenda, Kishan Patel, Nydia Jaimes-Delgadillo, Dominique Coletta, Takemi Tanaka, Ayal C. Walland, Zena Jameel, Srinivasa Vedantam, Sittinon ...> ;Breast. 2018 Jun 1
• 4 citations
  Real-world economic value of a 21-gene assay in early-stage breast cancer.
  Stanley E. Waintraub, Donna M. McNamara, Deena Graham, Andrew L. Pecora, John Min, Tommy Wu, Hyun gi Noh, Jacqueline Connors, Ruth Pe Benito, Kelly Choi, Eric V Schult...> ;The American Journal of Managed Care. 2017 Dec 1
• 141 citations
  Genomic Profiling of Advanced Non-Small Cell Lung Cancer in Community Settings: Gaps and Opportunities.
  Martin Gutierrez, Kelly Choi, Richard B. Lanman, Edward J. Licitra, Stanley M. Skrzypczak, Ruth Pe Benito, Tommy Wu, Srikesh Arunajadai, Sukhi Kaur, Harry D. Harper, A...> ;Clinical Lung Cancer. 2017 Apr 13
• 75 citations
  A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG‐ACRIN Cancer Research Group (E...
  Kevin Kalinsky, Sandra J. Lee, Krista M. Rubin, Donald P. Lawrence, Anthony J. Iafrarte, Darell R. Borger, Kim Margolin, Mario M. Leitao, Ahmad A. Tarhini, Henry B. Ko...> ;Cancer. 2017 Jul 15
• 50 citations
  Protein calorie malnutrition, nutritional intervention and personalized cancer care
  Anju Gangadharan, Sung-Eun Choi, Ahmed Hassan, Nehad M. Ayoub, Gina Durante, Sakshi Balwani, Young Hee Kim, Andrew L. Pecora, Andre Goy, K. Stephen Suh> ;Oncotarget. 2017 Feb 5
• 91 citations
  PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular...
  Arshed A. Quyyumi, Alejandro Vasquez, Dean J. Kereiakes, Marc Klapholz, Gary L. Schaer, Ahmed Abdel-Latif, Stephen Frohwein, Timothy D. Henry, Richard A. Schatz, Nabil...> ;Circulation Research. 2017 Jan 20
• Join now to see all

Journal Articles

• Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies  
  Baker M, Wang H, Rowley SD, Cai L, Pecora AL, Skarbnik A, Vesole DH, Adler-Brecher B, Kim D, Donato ML, Biol Blood Marrow Transplant, 1/1/2016
• Long-Term Survival Is Demonstrated in Patients with Multiple Myeloma Treated with Allogeneic Hematopoietic Stem Cell Transplantation in Both the Consolidation and Salv...  
  Phyllis McKiernan, David S. Siegel, David H. Vesole, Tracy Andrews, Scott D. Rowley, Noa Biran, Joshua R. Richter, Andrew L. Pecora, Alan P Skarbnik, Andre Goy and Mic..., Blood, 1/1/2016
• Impact of Charlson Comorbidity Index (CCI) and Refining the MIPI Index in Mantle Cell Lymphoma (MCL)  
  Andre Goy, MD, Tommy Wu, Eric Hansen, Srikesh Arunajadai, Ewelina Protomastro, Marisa Valentinetti, BSN, RN, Maureen Murphy, BSN, RN, Judith E Smith, BSN, RN, Ruth Pe ..., Blood, 1/1/2016
• Impact of Immune Reconstitution (IR) and Graft-Versus-Host Disease (GvHD) on Clinical Outcomes after Treatment with Donor T Cells Transduced to Express the Herpes Simp...  
  Fabio Ciceri, MD, Chiara Bonini, MD, Arnon Nagler, MD, Evangelia Yannaki, MD, Maria Teresa Lupo Stanghellini, MD, Attilio Bondanza, MD, PhD, Raffaella Greco, MD, Eduar..., Blood, 1/1/2016
• A Phase I/II Study of Escalating Doses of Bortezomib in Conjunction with High-Dose Melphalan as a Conditioning regimen for Salvage Autologous Peripheral Blood Stem Cel...  
  Biran N, Rowley SD, Vesole DH, Zhang S, Donato ML, Richter J, Skarbnik AP, Pecora A, Siegel DS, Biol Blood Marrow Transplant, 1/1/2016
• Characterization of Early Stage Breast Cancer Patient Management in a Practice Setting with 21-gene Breast Cancer Assay  
  Pecora A, Waintraub S, Choi K, Rothney M, Value in Health, 1/1/2015
• Barriers to physician adherence with evidence-based monitoring guidelines in chronic myelogenous leukemia  
  Goldberg S, Akard L, Dugan M, Federl S, Pecora A, J Oncol Practice, 1/1/2015
• Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and pappilary serous ovarian cancer subtypes  
  Tamir A, Jag U, Sarojini S, Schindewolf C, Tanaka T, Gharbaran R, Patel H, Sood A, Hu W, Blake P, Chirina P, Jeong J, Lim H, Goy A, Pecora A, Shuh, Journal of Ovarian Research, 1/1/2014
• Efficacy of HSV-TK+ suicide gene donor lymphocytes after haploidentical transplantation (haplo-HSCT): Preliminary results of randomized TK008 study  
  Fabio Ciceri, Chiara Bonini, Arnon Nagler, Evangelia Yannaki, Maria Teresa Lupo Stanghellini, Attilio Bondanza, Giacomo Oliveira, Raffaella Greco, Eduardo Olavarria, E..., J Clin Oncol, 1/1/2014
• Post-treatment PET scan is highly predictive of outcome (PFS and OS) in MCL pts treated with R-Hyper-CVAD in the frontline setting regardless of MIPI score  
  Anthony R. Mato, Ewelina Protomastro, Tania Zielonka, Tatyana Feldman, Harry Agress, Mary Timberg, Gabriella Gadaleta, Pritish Bhattacharyya, Alexandria Campaiola, Jak..., J Clin Oncol, 1/1/2014
• Addition of Lenolidomide to rituximab, ifosphamide, carboplatin, etoposide (RICER) in first relapse/primary refractory diffuse large B cell lymphoma  
  Feldman T Mato AR, Chow KF, Protomastro EA, Yannotti KM, Bhattacharyya P, Yang X, Donato ML, Rowley S, Carini C, Valentinetti M, Smioth J, Gadaleta G, Bejot C, Stives ..., Br J Haematol, 1/1/2014
• The graft-versus-myeloma effect: chronic graft versus host disease prolongs survival in patients with multiple myeloma receiving allogeneic transplantation  
  Donato ML, Siegel DS, Vesole DH, McKiernan P, Nyirenda T, Pecora Al, Baker M, Goldberg SL, Mato A, Goy A, Rowley SD, Biol Blood Marrow Transplant, 1/1/2014
• Phase II clinical trial of rapamycin-resistant donor CD4+ Th2/TH1 (T-Rapa) cells after low intensity allogeneic hematopoietic cell transplantation  
  Fowler, DH; Mossoba, ME; Steinberg, SM; Halverson, DC; Stroncek, D.; Khuu, HM; Haikim, FT; Castiello, L; Sabatino, M; Leitman, SF; Mariotti, J; Gea-Banacloche, JC; Spo..., Blood, 1/1/2013
• The role of the ubiquitin proteasome system in lymphoma  
  Suh, KS; Tanaka, T; Sarojini ,S; Nightingale, G; Gharbaran, R; Pecora, A; Goy, A, Oncol Hematol, 1/1/2013
• Focusing on clinical and economic outcomes � not guidelines  
  Pecora, A, Am J Managed Care, 1/1/2013
• Fibroblast growth factor-2(FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients  
  Gharbaran, R; Goy, A; Tanaka, T; Park, J; Kim, C; Hasan, N; Vemulapalli, S; Sarojini, S; Tuluc, M; Nalley, K; Bhattacharyya, P; Pecora, A; Suh, S, J Hematol Oncol, 1/1/2013
• Assessment of Myocardial Contractile Circumfrential strain following intracoronary stem cell infusion after myocardial infarction: MRI feature tracking feasibility study  
  Bhatti S, Al-Khalidi S, Hor H, Hakeem K, Taylor A, Quyyumi A, Oshinski A, Pecora Al, Keriakis D, Chung E, Pedrizzetti E, Miszakski G, Mazur T, ISRN Radiol, 1/1/2013
• Post-Treatment (not interim) PET-CT Scan Status Is Highly Predictive of Outcome In Mantle Cell Lymphoma Patients Treated with R-HyperCVAD  
  Mato A, Goy A, Pecora AL, et al, Cancer, 1/1/2012
• Three dimensional cell culture models for biomarker discoveries and Cancer Research  
  Caicedo-Carvajal CE, Liu Q, Goy A, Pecora A, Suh KS, Translational Medicine, 1/1/2012
• Intracoronary Bone Marrow Mononuclear Cells after Myocardial Infarction  
  A. Quyyumi MD, Andrew L. Pecora MD, JAMA, 1/1/2012
• Early detection biomarkers for ovarian cancer  
  Sarojini, S; Tamir, A; Lim, H; Li, S; Zhang, S; Goy, A; Pecora, A; Suh, KS, J. Oncology, 1/1/2012
• CD34+ cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent  
  Quyyumi A, Waller E, Murrow J, Esteves F, Galt J, Oshinski J, Lerakis S, Sher S, Vaughan D, Perin E, Willerson J, Kereiakes D, Gersh B, Gregory D, Werner A, Moss T, Ch..., American Heart Journal, 1/1/2011
• A phase III study of B4-blocked ricin as adjuvant therapy post-autologus bone marrow transplant: CALGB 9254  
  Furman RR, Grossbard ML, Johnson JL, Pecora AL, Cassileth PA, Jung SH, Peterson BA, Nadler LM, Freedman A, Bayer RL, Barlett NL, Hurd DD, Cheson BD, Leuk Lymphoma, 1/1/2011
• Phase 1 study of recombinant interleukin 7 administration in subjects with refractory malignancy  
  Sportes C, Babb R, Krumlauf M, Hakim F, Steinberg S, Chow C, Brown M, Fliesher T, Noel P, Maric I, Stetler-Stevenson M, Engel J, Buffet M, Moree M, Amato R, Pecora AL,..., Clin Cancer Res, 1/1/2010
• Incidence and clinical complications of myelodysplastic syndrome among United States Medicare beneficiaries  
  Goldberg S, Chen Er, Corral M, Mody-Patel N, Pecora AL, Laouri M, J Clin Oncol, 1/1/2010
• Join now to see all

Books/Book Chapters

• Gene Therapy for Cancer 
  Chapter: Phase I Clinical Experience with Intravenous Administration of PV 701 an Oncolytic Virus. Gene Therapy for Cancer. 
  Page 399.0 - 409.0Pecora AL and Lorence RMHumana Inc2007
• Autologous Blood and Marrow Transplant X: Proceedings of the Tenth International Symposium 
  Chapter: Lymphoma 
  Shenkheim D, Pecora AL Elfenbien G et alEditors: Dicke and Keating.2001
• Handbook of Bone Marrow Transplantation 
  Chapter: CD34+ Cell Selection and Ex Vivo Expansion In Autologous and Allogeneic Transplantation 
  Page 1.0 - 20.0Pecora ALMartin Dunitz Ltd2000
• Hematopoietic Stem Cell Transplantation 
  Chapter: CD34 Selection Using Immunomagnetic Beads 
  Page 223.0 - 229.0Preti RA, Pecora AL, Ahmed T, Farley JMarcel Dekker, Inc2000
• Stem Cell Quantification 
  Chapter: Stem Cell Quantification: The ISHAGE Guidelines For CD34+ Determination-Applications in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation 
  Page 298.0 - 311.0Sutherland DR, Keeney M, Pecora A, Chin-YeeChurchill Ltd2000
• Join now to see all

Abstracts/Posters

• Evomela¬ Significantly Increases the Risk of Engraftment Syndrome in Patients with Multiple Myeloma Treated with Autologous Stem Cell Transplantation
  Andrew L. Pecora, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Engraftment Syndrome in the Setting of Autologous Stem Cell Transplantation for Multiple Myeloma-a Single Institution Review of over 600 Patients
  Andrew L. Pecora, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Sustained Hematopoietic Recovery after Salvage Autologous Stem Cell Transplants after Long Term Storage of Cryopreserved Hematopoietic Progenitor Stem Cells (HPSC)
  Andrew L. Pecora, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Predictive value of the patient reported outcome �living with cancer� instrument on overall survival in advanced cancer patients: A tool for guiding timing of palliati...
  Goldberg SL, Paramanathan D, Arunajadai S, DeVincenzo V, Pe Benito R, Gruman B, Kaur S, Goy A, Niranjan U, Fitzgerald D, Childs JW, Lee JW, Abdo-Matkiwsky MD, Choi K, ..., J Clin Oncol, 1/1/2017
• Early economic benefits of gene expression profiling using a 21-gene panel among patients with early stage, lymph node negative, hormone receptor positive, her2-neu on...
  Waintraub SE, McNamara DM, Graham DA, et al, J Clin Oncol, 1/1/2016
• Inhibition of HIF Prolyl Hydroxylases Mitigate Gut Graft-Versus-Host Disease
  Rena Feinman, PhD, Iriana Colorado, MSc, Keyi Wang, MSc, Eugenia Dziopa, MSc, Michael A Flynn, MSc, Kevin Peters, MD, Andrew L. Pecora, MD and Robert Korngold, PhD, 1/1/2016
• 5-Day Decitabine with Mini Fludarabine and Busulfan Yields Comparable Outcomes to Mini Flu/Bu but with Increased Incidence of Severe Acute GvHD
  Melissa Baker, APN, Tracy Andrews, MA, Scott D. Rowley, MD, Andrew L. Pecora, MD, Alan P Skarbnik, MD, David H. Vesole, MD, PhD, Andre Goy, MD, Maria Cortes, APN, Ange..., 1/1/2016
• Impact of Charlson Comorbidity Index (CCI) and Refining the MIPI Index in Mantle Cell Lymphoma (MCL)
  Andre Goy, MD, Tommy Wu, Eric Hansen, Srikesh Arunajadai, Ewelina Protomastro, MS, Marisa Valentinetti, BSN, RN, Maureen Murphy, BSN, RN, Judith E Smith, BSN, RN, Ruth..., Blood, 1/1/2016
• Day Decitabine with Mini Fludarabine and Busulfan Yields Comparable Outcomes to Mini Flu/Bu but with Increased Incidence of Severe Acute GvHD
  Melissa Baker, APN, Tracy Andrews, MA, Scott D. Rowley, MD, Andrew L. Pecora, MD, Alan P Skarbnik, MD, David H. Vesole, MD, PhD, Andre Goy, MD, Maria Cortes, APN, Ange..., Blood, 1/1/2016
• Impact of Immune Reconstitution (IR) and Graft-Versus-Host Disease (GvHD) on Clinical Outcomes after Treatment with Donor T Cells Transduced to Express the Herpes Simp...
  Fabio Ciceri, MD, Chiara Bonini, MD, Arnon Nagler, MD, Evangelia Yannaki, MD, Maria Teresa Lupo Stanghellini, MD, Attilio Bondanza, MD, PhD, Raffaella Greco, MD, Eduar..., Blood, 1/1/2016
• Are Cancer Patients Concerned About Burdening Their Families?
  Pecora A, ASCO Palliative Care Symposium, 1/1/2016
• Validation of the Living With Cancer (LWC) PRO Tool for Identifying Cancer Patients (pts) Appropriate for End of Life Care Consultations
  Pecora A, ASCO Palliative Care Symposium, 1/1/2016
• Genomic Profiling of non-small cell lung cancer in the community setting
  Gutierrez M, Choi K, Lanman RB, Skrzypczak SM, et al, J Clin Oncol, 1/1/2016
• Growth factor use and costs in breast cancer patients undergoing adjuvant therapy
  Hyun gi Noh, Dhakshila Paramanathan, Kiran Suryadevara, Kelly Choi, Augie Smith, William Kea, Eric V Schultz, Andrew Pecora, Stuart L. Goldberg, J Clin Oncol, 1/1/2016
• Are patients with advanced cancer concerned about financial toxicity?
  Paramanathan D, Kaur S, Daswani S, et al, J Clin Oncol, 1/1/2016
• Characterization of Early Stage Breast Cancer Patient Management in a Practice Setting with the 21-Gene Breast Cancer Assay
  Pecora A, Waintraub S, Choi K, et al, Value in Medicine, 1/1/2015
• Utilization and clinical impact of genomic profiling for EGFR and ALK in non-squamous non-small cell lung cancer (NSCLC) in the community setting
  Gutierrez M, Harper HD, Halibey BE, Miller VA, Conway J, Oldroyd M, Choi K, Schultz EV, Pecora A, Goldberg SL, J Clin Oncol, 1/1/2015
• Prevalence of clinically meaningful prognostic variability in cancer: An analysis using a new taxonomy system
  Pecora A, Schultz EV, Choi K, Smith A, LaRock B, Paramanathan D, DeRosa WT, Goy A, Licitra EJ, Siegel DS, Goldberg SL, J Clin Oncol, 1/1/2015
• Novel Chromatin Modifying Gene Alterations and Significant Survival Association of ATM and P53 in Mantle Cell Lymphoma
  Kai Wang, MD, PhD, Michelle K. Nahas, PhD, Roman Yelensky, PhD, Geoff A. Otto, PhD, Doron Lipson, PhD, Jie He, PhD, Jeff Ross, MD, Phil J Stephens, PhD, Kar Fai Chow, ..., American Society of Hematology, 1/1/2014
• Haploidentical Allogeneic Transplantation Provides Comparable Outcomes to HLA-Matched or Mismatched Unrelated Donor Grafts in Hematological Malignancies
  Melissa F Baker, APN, Daniel Kim, Michele L Donato, MD, FACP, Andrew L Pecora, MD, FACP, David H. Vesole, MD, PhD, Alan P Skarbnik, MD, Barbara Adler-Brecher, Michele ..., American Society of Hematology, 1/1/2014
• Vascular Disease: Biology and Clinical Science Session Title: Novel Therapies and Treatment Strategies for Patients with Acute Coronary Syndromes
  A. Quyyumi, A. Vasquez,M. Klapholz D.J. Kereiakes, G.L. Schaer, K. Fujise, A. Abdel-Latif: R.S. Iwaoka, A.E. Denktas, R. Gammon, S.C. Frohwein, V. Kasi, M.R. Tamberell..., American Heart Association, 1/1/2014
• Safety and efficacy of ipilimumab in melanoma patients who received prior immunotherapy on phase III study MDX010-020
  Howard Kaufman, Jose Lutzky, Joseph Clark, Kim Allyson Margolin, David H. Lawson, Asim Amin, Frances A. Collichio, Andrew Pecora, Walter John Urba, Kelly L. Bennett, D..., J Clin Oncol, 1/1/2013
• Decitabine Plus Mini Fludarabine and Busulfan Yields Durable Engraftment with Low Relapse Rates in Elderly or Medically Infirm Patients with Myeloid Malignancies
  Baker Melissa F; Rowley Scott D.; Goldberg, Stuart L.; Mato Anthony R.; Pecora Andrew L.; Vesole, David H.; McKiernan Phyllis; Goy Andre; Donato Michele L., American Society of Hematology, 1/1/2012
• A Phase I/II Study of Escalating Doses of Thalidomide (Thal) in Conjunction with Brotezomib (Vel) and High Dose Melphalan (Mel) As A Conditioning Regimen for Autologou...
  Hong Sung H.; Siegel David S.; Donato Michele L.; Vesole David H.; Pecora Andrew L.; Richter Joshua R.; Brown Emily; Buttner Kathryn; DelFavero Marie; Kim Daniel; Orte..., American Society of Hematology, 1/1/2012
• Ricer (Rituximab, Ifosfamide, Carboplatin, Etoposide, Revlimid) Is Well-Tolerated Salvage Regimen in First Relapse/Primary Refractory DLBCL Allowing Consolidation with...
  Mato Anthony R.; Donato Michele L.; Rowley Scott D.; Goldberg Stuart L; Carini Carolanne; Valentinetti Marisa; Smith Judith; Gadaleta Gabriella; Bejot Coleen; Stives S..., American Society of Hematology, 1/1/2012
• Join now to see all

Lectures

• Phase I/II Study of Escalating Doses of Thalidomide in Conjunction with Bortezomib and High Dose Melphalan As a Conditioning Regimen for Autologous Stem Cell Transplan... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Safety and Efficacy Data for Combined Checkpoint Inhibition with Ipilimumab (Ipi) and Nivolumab (Nivo) As Consolidation Following Autologous Stem Cell Transplantation ... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Infusion of Donor Lymphocytes Genetically Engineered to Express the Herpes Simplex Virus Thymidine Kinase (HSV-TK) Suicide Gene after Haploidentical Hematopoietic Stem... 
  1/1/2014
• Pre-Emptive T-Rapa Cell DLI for Therapy of High Risk Lymphoma after Low-Intensity Allogeneic HCT 
  1/1/2012
• CD34+CXCR4+ cell therapy (AMR-001) for myocardial infarction: Preliminary processing and product results of a phase I Dose escalation study 
  1/1/2007
• Protect your Genes 
  Ridgewood, NJ - 1/1/2004
• Myelodysplastic Syndrome (MDS) and Leukemia After Autotransplant for Lymphoma: A Mulicenter Case Control Study 
  1/1/2001
• An Intravenous Phase I Trial of a Replication-competent Virus, PV701 in the Treatment of Advanced Cancers 
  1/1/2001
• Cell Processing; Experimental Stem Cell Mobilization II 
  1/1/2000
• Colloquium on Bone Marrow Transplant and Breast Cancer Trials 
  1/1/1999
• Future Trends In Stem Cell Therapies 
  Washington, DC - 1/1/1999
• Clinical Application of Stem Cell Expansion 
  San Francisco, CA - 1/1/1999
• What to Do For the Poor Mobilizing Patient 
  Ravenna, Italy - 1/1/1999
• The Effect of Induction Chemotherapy Prior to Sequential High Dose Chemotherapy 
  1/1/1999
• What to Do When You Can�t Collect Enough Cells for Transplant 
  Ravenna, Italy - 1/1/1999
• Breast Cancer Cell Contamination of Blood Stem Cell Products In Patients with Metastatic Breast Cancer: Predictors and Clinical Outcomes 
  1/1/1999
• Models for Facilitating Clinical Trials 
  1/1/1998
• CD34 Subsets and Engraftment 
  1/1/1998
• High-Dose Chemotherapy - Emerging Trends in Stem Cell Therapy 
  Phoenix, Arizona - 1/1/1998
• Changing Concepts In Breast Cancer 
  University of Pennsylvania Cancer Center - 1/1/1998
• Blood Stem Cell (BSC) Transplantation In Metastatic Breast Cancer Using CD34 Positive Selection With or Without Negative Selection for Tumor Cells Using the ISOLEX 300... 
  1/1/1998
• State of the Art in BMT 
  Methodist Healthcare System, San Antonio, Texas - 1/1/1997
• Contamination in Peripheral Blood Stem Cell (PBSC) Collections Association with Bone Marrow Disease and Type of Mobilization 
  Robert Woods Johnson Medical School - 1/1/1997
• Clinical Relevance and Application of Tumor Cell Depletion Using CD34+ Cell Selection or Ex-vivo Expansion 
  1/1/1997
• Advances in the Treatment of Breast Cancer 
  1/1/1997
• Join now to see all